Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019

Choline kinase alpha (CHKA) is a promising target for the development of cancer therapeutics. We have previously reported ICL-CCIC-0019, a potent CHKA inhibitor with high cellular activity but with some unfavorable pharmacological properties. In this work, we present an active analogue of ICL-CCIC-0...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ning, Brickute, Diana, Braga, Marta, Barnes, Chris, Lu, Haonan, Allott, Louis, Aboagye, Eric O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309005/
https://www.ncbi.nlm.nih.gov/pubmed/34371769
http://dx.doi.org/10.3390/pharmaceutics13071078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309005/
https://www.ncbi.nlm.nih.gov/pubmed/34371769
http://dx.doi.org/10.3390/pharmaceutics13071078

Ejemplares similares